Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers. Sep 2011 - Cancer Immunol. Immunother.; 60(10):1432-0851 [PMID:21638124] [Shindo G] [Endo T] [Onda M] [Miyamoto Y] [Kaneko T] [Goto S]
A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Mrz 2009 - Pancreas; 38(3):1536-4828 [PMID:19276867] [Hirooka Y] [Itoh A] [Kawashima H] [Hara K] [Nonogaki K] [Kasugai T] [Ohno E] [Ishikawa T] [Matsubara H] [Ishigami M] [Katano Y] [Ohmiya N] [Niwa Y] [Yamamoto K] [Kaneko T] [Nieda M] [Yokokawa K] [Goto H]
Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer. Nov 2005 - Anticancer Res.; 25(6A):0250-7005 [PMID:16302730] [Kaneko T] [Goto S] [Kato A] [Akeyama A] [Tomonaga M] [Fujimoto K] [Miyamoto Y] [Eriguchi M] [Egawa K]
Combined immunocell therapy using activated lymphocytes and monocyte-derived dendritic cells for malignant melanoma. Nov 2005 - Anticancer Res.; 25(6A):0250-7005 [PMID:16302734] [Goto S] [Kaneko T] [Miyamoto Y] [Eriguchi M] [Kato A] [Akeyama T] [Fujimoto K] [Tomonaga M] [Egawa K]
